Insider Selling Sparks Questions at Tevogen Bio Neal Flomenberg, Tevogen Bio's Chief Scientific Officer, sold $253,935 worth of shares to cover tax obligations related to restricted stock units. While the company emphasizes this was a routine transaction, investors are scrutinizing insider activity amid broader concerns about the firm's financial health and stock performance.34